Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure.
Condition:   Heart Failure Interventions:   Drug: Furosemide Pill 150% equivalent iv dose;   Drug: Furosemide Pill 200% equivalent iv dose;   Drug: Furosemide Injection Sponsor:   Jan Kochanowski University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
Condition:   Heart Failure Interventions:   Drug: Furosemide Pill 150% equivalent iv dose;   Drug: Furosemide Pill 200% equivalent iv dose;   Drug: Furosemide Injection Sponsor:   Jan Kochanowski University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure.
Condition:   Heart Failure Interventions:   Drug: Furosemide Pill 150% equivalent iv dose;   Drug: Furosemide Pill 200% equivalent iv dose;   Drug: Furosemide Injection Sponsor:   Jan Kochanowski University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
Condition:   Heart Failure Interventions:   Drug: Furosemide Pill 150% equivalent iv dose;   Drug: Furosemide Pill 200% equivalent iv dose;   Drug: Furosemide Injection Sponsor:   Jan Kochanowski University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2022 Category: Research Source Type: clinical trials

Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
DiscussionA finding of non-inferiority in efficacy of oral fluoroquinolones or trimethoprim-sulfamethoxazole versus IV standard of care antibiotics may hypothetically translate to wider adoption of a more cost-effective treatment strategy with better quality of life outcomes.Trial registrationClinicalTrials.govNCT05199324. Registered 20 January 2022. (Source: Trials)
Source: Trials - July 19, 2022 Category: Research Source Type: clinical trials

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
Conditions:   Anxiety Disorders and Symptoms;   Fibromyalgia;   Arthritis;   Chronic Pain;   Hypertension,Essential Interventions:   Dietary Supplement: IV Vitamin Infused Therapy Treatment;   Drug: Herbal medicine Sponsor:   Faith A. Richardson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2021 Category: Research Source Type: clinical trials